Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Biliary Tract Neoplasms 1

Interventions

Oxaliplatin 86 Bevacizumab 66 Capecitabine 65 Fluorouracil 48 tislelizumab 41 Gemcitabine 40 Drug Therapy 39 Leucovorin 38 sintilimab 35 Irinotecan 34 lenvatinib 27 Cisplatin 27 HMPL-013 25 S 1 (combination) 23 camrelizumab 22 Immune Checkpoint Inhibitors 21 irinotecan sucrosofate 20 apatinib 20 Surgical Procedures, Operative 20 Radiotherapy 20 Injections 20 130-nm albumin-bound paclitaxel 20 toripalimab 19 Paclitaxel 18 Folfox protocol 17 pembrolizumab 15 Immunotherapy 15 Cetuximab 15 Specimen Handling 14 regorafenib 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × mitazalimab × Gastrointestinal × Clear all

NCT07437287 2026-02-27

CROCOBIL

UNICANCER

Phase 2/3 Not yet recruiting

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡